Two Sigma Advisers’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Two Sigma Advisers’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-34,500	Closed	-$3.99M	–	2710
2023 Q3	$3.99M	Sell	34,500 -291,600	-89%	-$33.7M	0.01%	846
2023 Q2	$33.5M	Buy	326,100 +46,300	+17%	+$4.76M	0.09%	218
2023 Q1	$30.5M	Buy	279,800 +121,500	+77%	+$13.3M	0.08%	240
2022 Q4	$18M	Sell	158,300 -218,600	-58%	-$24.9M	0.05%	370
2022 Q3	$23.3M	Buy	376,900 +364,400	+2,915%	+$22.6M	0.07%	287
2022 Q2	$997K	Buy	+12,500	New	+$997K	﹤0.01%	1595
2022 Q1	–	Sell	-11,100	Closed	-$1.2M	–	3025
2021 Q4	$1.2M	Buy	+11,100	New	+$1.2M	﹤0.01%	1467
2021 Q2	–	Sell	-62,600	Closed	-$5.76M	–	2831
2021 Q1	$5.76M	Sell	62,600 -440,900	-88%	-$40.6M	0.02%	797
2020 Q4	$36.8M	Buy	503,500 +37,600	+8%	+$2.75M	0.1%	218
2020 Q3	$36.2M	Buy	465,900 +75,898	+19%	+$5.9M	0.1%	194
2020 Q2	$21.7M	Buy	390,002 +17,373	+5%	+$966K	0.06%	305
2020 Q1	$11M	Sell	372,629 -445,500	-54%	-$13.2M	0.04%	452
2019 Q4	$29.6M	Buy	818,129 +1,500	+0.2%	+$54.3K	0.07%	302
2019 Q3	$22.2M	Sell	816,629 -259,500	-24%	-$7.07M	0.05%	343
2019 Q2	$25.9M	Buy	1,076,129 +4,400	+0.4%	+$106K	0.06%	337
2019 Q1	$28.3M	Sell	1,071,729 -15,400	-1%	-$407K	0.07%	324
2018 Q4	$21.2M	Buy	1,087,129 +544,100	+100%	+$10.6M	0.06%	362
2018 Q3	$10.6M	Buy	543,029 +181,300	+50%	+$3.55M	0.03%	563
2018 Q2	$5.99M	Buy	361,729 +193,800	+115%	+$3.21M	0.02%	779
2018 Q1	$2.39M	Buy	167,929 +121,900	+265%	+$1.73M	0.01%	1167
2017 Q4	$672K	Buy	+46,029	New	+$672K	﹤0.01%	1671
2017 Q2	–	Sell	-19,629	Closed	-$290K	–	2475
2017 Q1	$290K	Buy	+19,629	New	+$290K	﹤0.01%	2099
2016 Q1	–	Sell	-16,429	Closed	-$356K	–	2194
2015 Q4	$356K	Buy	+16,429	New	+$356K	﹤0.01%	1460
2015 Q2	–	Sell	-33,400	Closed	-$867K	–	2152
2015 Q1	$867K	Buy	+33,400	New	+$867K	0.01%	1136
2014 Q3	–	Sell	-18,200	Closed	-$288K	–	2128
2014 Q2	$288K	Buy	+18,200	New	+$288K	﹤0.01%	1591